Drugs / glyceryl Eicosapentaenoate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06155513 | Dec 2023 → Nov 2025 | atopic eczema | SCF Pharma | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glyceryl Eicosapentaenoate | “Daily application of glyceryl Eicosapentaenoate serum and glyceryl Eicosapentaenoate cream of formulation A on the targeted skin area.” NCT06155513 ↗ |
| Route | Topical | “Omega-3 monoglyceride based topical Serum and cream of formulation A (light)” NCT06155513 ↗ |